Mode of treatment governs curcumin response on doxorubicin-induced toxicity in cardiomyoblasts
- 265 Downloads
Doxorubicin (Dox) is an effective anti-cancer drug with severe reported cardiotoxicity. Cardiovascular risks associated with present cancer therapeutics demand urgent attention. There has been a growing interest in naturally occurring compounds to improve the therapeutic index as well as prevent non-tumour tissues from sustaining chemotherapy-induced damages. In the present study, the effects of curcumin, a polyphenol isolated from Curcuma longa and well known for its anti-oxidative, anti-cancerous and anti-inflammatory properties, was studied in relation to the Dox-induced cardiotoxicity. As literature suggests conflicting role of curcumin in Dox-induced cardiotoxicity, concentration- and time-dependent studies were conducted to study the different curcumin effects. H9C2 cardiomyoblasts were used in the study and cell viability assays were done to study Dox-induced cellular death. Drug uptake assay for Dox was performed followed by cellular growth inhibition analysis by FACS Calibur. Morphological alterations, intracellular ROS levels and mitochondrial integrity were observed by fluorescent-based microscopic studies. Catalases and superoxide dismutase-inbuilt anti-oxidant enzyme activities were studied, and it was observed that Dox-dependent cardiotoxicity occurs through ROS overproduction by exaggerating the inbuilt anti-oxidant mechanism. Expression analysis for cell death and ROS markers—BCl2, Bax, SOD, catalase—was investigated by semi-quantitative RT-PCR, and the Dox-induced stress on cardiac cells was confirmed. Initiator and effector caspases activity analysis also confirmed these findings. Our study proposes that curcumin exerts time-dependent responses on Dox-induced cardiotoxicity, where parallel treatment potentiates and pre-treatment suppresses the Dox-induced toxicity in H9C2 cardiomyoblasts. In conclusion, pre-treatment of curcumin suppresses the Dox-induced cardiotoxicity and holds a great potential as future cardio-oncological therapeutics.
KeywordsAnti-cancerous drug Doxorubicin Cardiotoxicity Curcumin Reactive oxygen species Anti-oxidant
This work was supported by a research grant awarded to Dr. Vibha Rani by the Department of Biotechnology (DBT), Government of India (BT/PR3978/17/766/2011). We acknowledge the Department of Biotechnology, Govt. of India and Jaypee Institute of Information Technology, deemed to be University for providing the funds and infrastructural support. We also acknowledge Dr. Manish Sharma, Scientist D, Peptide and Proteomics Division, Defence Institute of Physiology and Allied Sciences (DIPAS), DRDO, Delhi, India, for providing FACS facility.
Compliance with ethical standards
Conflict of interest
There is no conflict of interest among the authors of the manuscript.
- 1.World Health Organization, Media Centre, Fact Sheets (2014) The top 10 causes of death. http://www.who.int/mediacentre/factsheets/fs310/en/. Accessed 28 April 2016
- 15.Thandavarayan RA, Giridharan VV, Arumugam S, Suzuki K, Ko KM, Krishnamurthy P, Watanabe K, Konishi T (2015) Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling. PLoS ONE 10(3):e0119214CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Chhabra A, Jaiswal A, Malhotra U, Rani V (2011) Effect of curcumin on matrix metalloproteinases screened in norepinephrine induced cardiac hypertrophy. J Comput Int Bioinf 4:1–10Google Scholar
- 31.Linnik OO, Drevytska TI, Gonchar OO, Chornyy SA, Kovalyov OM, Mankovska IM (2016) Doxorubicin-induced alterations in pro-and antioxidant balance and their correction by curcumin in the neonatal rat cardiomyocytes culture. FiziolZh 61(5):90–98Google Scholar
- 45.Aebi HE (1983) Catalase. In: Bergmeyer HU (ed) Methods of enzymatic analysis, vol 3. Verlag Chemie, Weinheim, pp 273–286Google Scholar
- 59.Buhrmann C, Mobasheri A, Busch F, Aldinger C, Stahlmann R, Montaseri A, Shakibaei M (2011) Curcumin modulates nuclear factor kappa B (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem 286:28556–28566CrossRefPubMedPubMedCentralGoogle Scholar
- 60.Marquardt JU, Gomez-Quiroz L, Arreguin Camacho LO, Pinna F, Lee YH, Kitade M, Dominguez MP, Castven D, Breuhahn K, Conner EA, Galle PR, Andersen JB, Factor VM, Thorgeirsson SS (2015) Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer. J Hepatol S0168–8278:301–303Google Scholar